Skip to Content
Merck
  • Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells.

Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells.

Nature methods (2015-12-01)
Matthew R Kudelka, Aristotelis Antonopoulos, Yingchun Wang, Duc M Duong, Xuezheng Song, Nicholas T Seyfried, Anne Dell, Stuart M Haslam, Richard D Cummings, Tongzhong Ju
ABSTRACT

Protein O-glycosylation has key roles in many biological processes, but the repertoire of O-glycans synthesized by cells is difficult to determine. Here we describe an approach termed Cellular O-Glycome Reporter/Amplification (CORA), a sensitive method used to amplify and profile mucin-type O-glycans synthesized by living cells. Cells convert added peracetylated benzyl-α-N-acetylgalactosamine to a large variety of modified O-glycan derivatives that are secreted from cells, allowing for easy purification for analysis by HPLC and mass spectrometry (MS). Relative to conventional O-glycan analyses, CORA resulted in an ∼100-1,000-fold increase in sensitivity and identified a more complex repertoire of O-glycans in more than a dozen cell types from Homo sapiens and Mus musculus. Furthermore, when coupled with computational modeling, CORA can be used for predictions about the diversity of the human O-glycome and offers new opportunities to identify novel glycan biomarkers for human diseases.